This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.

This fact sheet provides Health Care Practitioners and Disaster Responders with guidelines for communicating with survivors experiencing grief. It give background information about the grieving process and what happens when the grief process is interrupted and complicated or traumatic grief occurs is included as well as helpful resources for additional assistance.

This manual lists examples of brief intervention and brief treatment for alcohol and drug misuse. It offers criteria for providing brief therapy and longer-term treatment. The manual also provides sample brief-assessment instruments, and lists other professionals who can provide brief interventions.

This manual describes brief intervention and therapy techniques for the treatment of alcohol and drug misuse.

In a disaster, it's essential that behavioral health responders have the resources they need—when and where they need them. The free SAMHSA Disaster App offers first responders immediate access for any type of traumatic event at every phase of response, including pre-deployment preparation, on-the-ground assistance and post-deployment resources.

This guide reviews screening tools for alcohol use and interventions for pregnant women and women of childbearing age to prevent fetal alcohol spectrum disorders (FASD). It also outlines methods for identifying people living with FASD and modifying treatment accordingly. Access the literature review.

This manual provides clinical practice guidelines for using medications in the medication-assisted treatment of alcohol use disorder. It offers guidance on prescribing acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The manual also discusses patient management. Access the literature review.